|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Sep―18 |
Population Pharmacokinetics of Casirivimab and Imdevimab in Pediatric and Adult Non-Infected Individuals, Pediatric and Adult Ambulatory or Hospitalized Patients or Household Contacts of Patients Infected with SARS-COV-2 |
Kuan-Ju Lin, Kenneth C. Turner, Maria Rosario, Lutz O. Harnisch, John D. Davis, A. Thomas DiCioccio |
2 |
[GO] |
2022―Sep―26 |
Preventing SARS-CoV-2 Infection Using Anti-spike Nanobody-IFN-β Conjugated Exosomes |
Xiabing Lyu, Shota Imai, Tomoyoshi Yamano, Rikinari Hanayama |
3 |
[GO] |
2022―Jul―28 |
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys |
Jilei Jia, Zhaojuan Yin, Xiao Zhang, Huimin Li, Dan Meng, Qianqian Liu, Hongfang Wang, Meng Han, Shixiang Suo, Yan Liu, Ping Hu, Chunyun Sun, Jing Li, Liangzhi Xie |
4 |
[GO] |
2022―Jul―01 |
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens |
Shobha Upreti, Mukesh Samant |
5 |
[GO] |
2020―Oct―06 |
A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality |
Rima Hajjo, Alexander Tropsha |
6 |
[GO] |
2020―Aug―10 |
Repurposing of Kinase Inhibitors for Treatment of COVID-19 |
Ellen Weisberg, Alexander Parent, Priscilla L. Yang, Martin Sattler, Qingsong Liu, Qingwang Liu, Jinhua Wang, Chengcheng Meng, Sara J. Buhrlage, Nathanael Gray, James D. Griffin |
7 |
[GO] |
2020―May―25 |
Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19 |
Nancy Baker, Antony J. Williams, Alexander Tropsha, Sean Ekins |
|